Skip to content


24th Annual SoCalBio Conference

 October 6, 2022 – October 7, 2022 
Westin Long Beach
SoCalBio is a nonprofit, member-supported trade association that promotes life-science research, development, manufacturing, job creation and overall economic growth in the six counties of the Greater Los Angeles region (Los Angeles, Orange, Ventura, Santa Barbara, Riverside, and San Bernardino). The Council’s programs help local firms gain access to capital, potential partners and business support services. The annual SoCalBio Investor & Partnering Conference has grown to become the region’s premier showcase for emerging life-science companies and digital health companies.

This year, the SoCalBio Conference will feature:

  • About 30 emerging, pre-screened, and mentored bioscience companies,
  • High-quality keynote presentations touching on market and technology trends,
  • Plenary sessions
  • Ample opportunities for networking


Day 1, October 6, 2022

1:00 PMRegistration Start
1:00 PM – 5:00 PMSetting up Exhibits
5:00 PMCocktail Reception, Networking, Visit Exhibits
6:00 PMSit-Down Dinner
7:00 PMTeconomy Presentation :
The 2022 State of the Bioscience Industry in Greater Los Angeles
7:45 PMPanel Discussion:
What is New in Supporting Industry Growth in the Greater Los Angeles Metro Region:
Sorting the Signals from Noise
Real Estate – Funding – Technical Services – Incubators – Talent Acquisition – Tech Transfer
8:30 PMDay one adjournment

Day 2, October 7, 2022

7:00 AMBreakfast & Sponsor Display Set up
8:30 AMSoCalBio Introductions and Sponsor Recognition
8:45 AMAcknowledging the SoCalBio Innovation Catalysts
9:00 AMKeynote Presentations:
The Biology/Engineering Conversion and the Rise of Integrative Biology
  • A Biotech Perspective by Phil Tagari , PhD , VP of Research, Amgen
  • A MedTech Perspective by Robert Greenberg, MD, PhD , Chair, Alfred Mann Foundation for Biomedical Enginering
10:00 AMBreak
10:15 AMThe Promise of Integrative Biology/Multi
Omics Paradigm
  • Enabling Precision Medicine: A Panel Discussion by the Terasaki Institute
11:15 AM

Precision Medicine:

  • The Journey from Science To Value
12:00 PMLunch
 Technologies FrontierBusiness TrendsEmerging Co. Presentations
1:00 PMThe Hunt for Biomarkers:
Enabling post genomic personalized medicine, and emerging technology governance to move systems science into clinical practice
Keynote Presentation:
  • Kara Bortone, PhD, Sr. Director, Diagnostics & Enabling Technologies, Janssen Business Development at Johnson & Johnson


  • James Berenson, MD, President, ONCOtracker , Inc
  • Robert Terbrueggen , PhD, President & CEO, DxTerity Diagnostics
  • Hsian Rong Tseng, Ph.D. D., Founder, Eximius
Funding Trends:
Who is Getting Money and Why in the Current Market?
Keynote Presentation:
  • Milo Bissin , Director, Silicon Valley Bank


  • Wavemaker 360
  • Vida Ventures
  • Bold Capital
  • Tech Coast Angels
  • Keiretsu SoCal
  • Section 32
5 Emerging Companies
2:00 PMBiometrics and Computational
Technologies in Cancer Treatment
How AI Helps in Predicting and
Managing Cancer Drugs’ Adverse Events
Keynote Presentation:
  • John Shon, Chief Technology Officer, SerImmune Inc.


  • TBA
Options for Emerging
Partnering Strategies in the Current Tight Funding Environment
  • Sanjay Mistry, Vice President Johnson & Johnson Innovation
  • Kanad Das, Investment Director, Boehringer Ingelheim Venture Fund
  • Amgen
  • Michael Martin, PhD, Global Head of Takeda Ventures
  • Medtronic
5 Emerging Companies
3:00 PMCoffee & Cookies Break
3:15 PMSmart Surgery:
A New Area in Surgical Technologies that Enable Precision MedTech Care
Keynote Presenter:
  • Jean Pierre Hubschman , MD, Founder, Horizon Surgical Devices


  • J&J
  • Others TBA
Los Angeles Area Incubators:
Are they Really Serving the Local Economy?
What Are the Metrics to Assess Performance?
  • Christopher Buser , PhD, Oak Crest Institute
  • Jamey Edwards, COO, Startup Health
  • Nick Mourlas , Head of JLABS San Diego
5 Emerging Companies
4:15 PMEnabling a Distributed
Healthcare Regime:
Precision Medicine in Homecare Through Remote, Medical Grade Monitoring with Wearables and Other Smart Devices
Keynote Presenter:
  • Ruey Kang Chang, MD, MPH, CEO, QT Medical, Inc.
  • TBA
Talent Development:
Will Double Majoring in Biology and Engineering Lead to Better Bioscience Industry Career Pathways?
  • Christopher Buser , PhD, Oak Crest Institute
  • Song Li, PhD, Chair of Bioengineering, UCLA
  • Various Execs TBA
5 Emerging Companies
5:15 PMClosing Cocktail Reception with Awards to Company Presenters
7:00 PMConference Adjourns